SCHEMBL16179771

SCHEMBL16179771

CN(C)C(=O)COc1ccc2c(c1)N(c1nc(-c3ccc(F)s3)nc3c1CCC3)CC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.34
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ KDR P35968 1/20 0.31
▸ PDK2 Q15119 1/20 0.31
▸ PDE7A Q13946 1/20 0.31
▸ LMNA P02545 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17476907 0.91 GRIN2B (0.35) GPR84HDAC1HDAC8HDAC6NPC1
SCHEMBL17476950 0.90 GPR84 (0.32) GPR84TP53GRIN1GRIN2BALDH1A1
SCHEMBL16179853 0.89 HDAC1 (0.33) GPR84HDAC1HDAC8HDAC6NPC1
SCHEMBL16179620 0.89 KDR (0.34) GPR84HDAC1HDAC8HDAC6NPC1
SCHEMBL16179709 0.89 GRIN1 (0.32) GPR84TP53GRIN1GRIN2BALDH1A1
SCHEMBL17476949 0.89 ALDH1A1 (0.33) GPR84TP53GRIN1GRIN2BALDH1A1
SCHEMBL17477055 0.84 MEN1 (0.41) GPR84NPC1MAPTTP53TSHR
SCHEMBL17476899 0.83 NPC1 (0.32) GPR84HDAC1HDAC8HDAC6NPC1
SCHEMBL16179782 0.82 PDE4B (0.46) MAPTALDH1A1MEN1HTTKMT2A
SCHEMBL17476914 0.81 GRIN2B (0.34) GPR84TP53GRIN1GRIN2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2986600-B1 SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS GRUENENTHAL GMBH (DE) 2017-07-05 — — EP disclosed
US-9527832-B2 Substituted condensed pyrimidine compounds Grünenthal GmbH (DE) 2016-12-27 — — US disclosed
EP-2986600-A1 SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-02-24 — — EP disclosed
US-20160031857-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-02-04 — — US disclosed
WO-2014170020-A1 SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2014-10-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031857-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS TYMP, PDE4A, DPYD GPR84 1079/4885HDAC1 539/4885HDAC8 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback